HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Progestin-releasing intrauterine systems.

Abstract
The levonorgestrel-releasing intrauterine system (LNG IUS) is an effective method for contraception. It has a strong antiproliferative action on the endometrium. The endometrium is transformed under the influence of local levonorgestrel and becomes unresponsive to ovarian estrogens. This process is associated with progressive reduction of menstrual blood loss and menstrual duration. Scanty and irregular bleeding and/or spotting is usual during the first 3 to 4 months. The reduction of menstrual blood loss continues and after the first 9 months many women have no bleeding at all. However, they have normal ovarian function. The absence of bleeding is a result of the local antiproliferative action of the LNG IUS on the endometrium, which is also responsible for many health benefits during the use of this method. As with oral contraceptives, the risk of pelvic inflammatory disease is reduced, because of reduced menstrual blood loss, endometrial suppression, and thickening of the cervical mucus. There are some steroidal side effects: mood changes, oily skin, and acne. Weight increase is similar to that associated with copper intrauterine devices: 500 g per year over 5 years. Users should be told that the LNG IUS does not prevent sexually transmitted infection, and therefore women at risk should also use condoms for their protection.
AuthorsT Luukkainen, P Pakarinen, J Toivonen
JournalSeminars in reproductive medicine (Semin Reprod Med) Vol. 19 Issue 4 Pg. 355-63 (Dec 2001) ISSN: 1526-8004 [Print] United States
PMID11727177 (Publication Type: Journal Article, Review)
Chemical References
  • Contraceptive Agents, Female
  • Progesterone Congeners
  • progestasert (progesterone-IUD)
  • Progesterone
  • Levonorgestrel
Topics
  • Acne Vulgaris (etiology)
  • Clinical Trials as Topic
  • Contraceptive Agents, Female (administration & dosage, adverse effects)
  • Depression (etiology)
  • Endometrium (drug effects, physiology)
  • Female
  • Humans
  • Intrauterine Devices, Medicated
  • Levonorgestrel (administration & dosage)
  • Pregnancy
  • Progesterone (administration & dosage)
  • Progesterone Congeners (administration & dosage)
  • Uterine Hemorrhage (etiology)
  • Uterine Perforation (etiology)
  • Weight Gain (drug effects)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: